Pacific Biosciences of California, Inc. (PACB)
USD 1.19
(0.42%)
USD 1.19
(0.42%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.74 Billion USD | -1.19% |
| 2022 | 1.76 Billion USD | -11.95% |
| 2021 | 2 Billion USD | 384.8% |
| 2020 | 413.98 Million USD | 179.74% |
| 2019 | 147.98 Million USD | -13.09% |
| 2018 | 170.27 Million USD | 18.18% |
| 2017 | 144.08 Million USD | 4.5% |
| 2016 | 137.88 Million USD | 5.17% |
| 2015 | 131.1 Million USD | 5.29% |
| 2014 | 124.52 Million USD | -8.56% |
| 2013 | 136.18 Million USD | 5.01% |
| 2012 | 129.68 Million USD | -40.6% |
| 2011 | 218.31 Million USD | -28.6% |
| 2010 | 305.74 Million USD | 202.43% |
| 2009 | 101.09 Million USD | -10.62% |
| 2008 | 113.1 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 1.66 Billion USD | -4.36% |
| 2024 Q2 | 1.5 Billion USD | -9.61% |
| 2023 FY | 1.74 Billion USD | -1.19% |
| 2023 Q2 | 1.84 Billion USD | -2.57% |
| 2023 Q3 | 1.89 Billion USD | 2.75% |
| 2023 Q4 | 1.74 Billion USD | -8.02% |
| 2023 Q1 | 1.89 Billion USD | 7.32% |
| 2022 Q3 | 1.81 Billion USD | -3.05% |
| 2022 Q4 | 1.76 Billion USD | -2.85% |
| 2022 FY | 1.76 Billion USD | -11.95% |
| 2022 Q1 | 1.93 Billion USD | -3.5% |
| 2022 Q2 | 1.87 Billion USD | -3.13% |
| 2021 Q2 | 1.24 Billion USD | -0.57% |
| 2021 Q3 | 2.03 Billion USD | 63.28% |
| 2021 Q4 | 2 Billion USD | -1.34% |
| 2021 FY | 2 Billion USD | 384.8% |
| 2021 Q1 | 1.25 Billion USD | 202.64% |
| 2020 Q3 | 300.31 Million USD | 40.57% |
| 2020 Q2 | 213.64 Million USD | -8.99% |
| 2020 Q1 | 234.76 Million USD | 58.64% |
| 2020 Q4 | 413.98 Million USD | 37.85% |
| 2020 FY | 413.98 Million USD | 179.74% |
| 2019 Q1 | 185.57 Million USD | 8.99% |
| 2019 Q3 | 146.11 Million USD | -14.35% |
| 2019 FY | 147.98 Million USD | -13.09% |
| 2019 Q4 | 147.98 Million USD | 1.28% |
| 2019 Q2 | 170.58 Million USD | -8.08% |
| 2018 Q4 | 170.27 Million USD | -6.91% |
| 2018 FY | 170.27 Million USD | 18.18% |
| 2018 Q3 | 182.9 Million USD | 33.45% |
| 2018 Q1 | 156.94 Million USD | 8.93% |
| 2018 Q2 | 137.05 Million USD | -12.67% |
| 2017 Q3 | 157.9 Million USD | -11.24% |
| 2017 FY | 144.08 Million USD | 4.5% |
| 2017 Q4 | 144.08 Million USD | -8.75% |
| 2017 Q1 | 135.5 Million USD | -1.72% |
| 2017 Q2 | 177.9 Million USD | 31.29% |
| 2016 Q3 | 150.63 Million USD | -6.65% |
| 2016 FY | 137.88 Million USD | 5.17% |
| 2016 Q1 | 140.17 Million USD | 6.92% |
| 2016 Q2 | 161.37 Million USD | 15.12% |
| 2016 Q4 | 137.88 Million USD | -8.46% |
| 2015 Q4 | 131.1 Million USD | 31.4% |
| 2015 Q2 | 96.77 Million USD | -9.07% |
| 2015 Q1 | 106.42 Million USD | -14.54% |
| 2015 FY | 131.1 Million USD | 5.29% |
| 2015 Q3 | 99.77 Million USD | 3.11% |
| 2014 Q4 | 124.52 Million USD | 2.37% |
| 2014 Q3 | 121.64 Million USD | -5.15% |
| 2014 Q2 | 128.24 Million USD | -9.07% |
| 2014 FY | 124.52 Million USD | -8.56% |
| 2014 Q1 | 141.04 Million USD | 3.57% |
| 2013 Q2 | 134.27 Million USD | -3.93% |
| 2013 Q4 | 136.18 Million USD | -10.87% |
| 2013 Q3 | 152.8 Million USD | 13.79% |
| 2013 Q1 | 139.77 Million USD | 7.78% |
| 2013 FY | 136.18 Million USD | 5.01% |
| 2012 FY | 129.68 Million USD | -40.6% |
| 2012 Q4 | 129.68 Million USD | -12.5% |
| 2012 Q3 | 148.2 Million USD | -12.78% |
| 2012 Q2 | 169.93 Million USD | -12.74% |
| 2012 Q1 | 194.73 Million USD | -10.8% |
| 2011 Q2 | 261.22 Million USD | -6.22% |
| 2011 Q1 | 278.55 Million USD | -8.89% |
| 2011 Q4 | 218.31 Million USD | -8.26% |
| 2011 Q3 | 237.96 Million USD | -8.9% |
| 2011 FY | 218.31 Million USD | -28.6% |
| 2010 FY | 305.74 Million USD | 202.43% |
| 2010 Q3 | 129.93 Million USD | -15.02% |
| 2010 Q2 | 152.89 Million USD | 0.0% |
| 2010 Q4 | 305.74 Million USD | 135.31% |
| 2009 FY | 101.09 Million USD | -10.62% |
| 2009 Q4 | 101.09 Million USD | 0.0% |
| 2008 FY | 113.1 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | -5466.578% |
| BrainsWay Ltd. | 62.97 Million USD | -2672.682% |
| Cerus Corporation | 197.74 Million USD | -782.949% |
| Envoy Medical, Inc. | 7.64 Million USD | -22753.573% |
| electroCore, Inc. | 16.38 Million USD | -10554.867% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -22599.077% |
| IceCure Medical Ltd | 16.41 Million USD | -10539.933% |
| Inogen, Inc. | 326.19 Million USD | -435.268% |
| OrthoPediatrics Corp. | 449.58 Million USD | -288.36% |
| Lucid Diagnostics Inc. | 27.27 Million USD | -6302.688% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -10431.468% |
| MaxCyte, Inc. | 268.27 Million USD | -550.832% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -21462.866% |
| Nexalin Technology, Inc. | 3.63 Million USD | -47974.157% |
| Orthofix Medical Inc. | 925.31 Million USD | -88.694% |
| PAVmed Inc | 33.11 Million USD | -5171.938% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | -1117.141% |
| RxSight, Inc. | 182.55 Million USD | -856.457% |
| Sight Sciences, Inc. | 166.65 Million USD | -947.706% |
| SI-BONE, Inc. | 230.42 Million USD | -657.736% |
| TELA Bio, Inc. | 78.04 Million USD | -2137.102% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | -593.118% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -16172.255% |
| Acutus Medical, Inc. | 53.96 Million USD | -3135.754% |
| Talis Biomedical Corporation | 98.34 Million USD | -1675.486% |
| Spectral AI, Inc. | 10.69 Million USD | -16230.088% |
| Nano-X Imaging Ltd. | 218.64 Million USD | -698.55% |
| CVRx, Inc. | 115.22 Million USD | -1415.255% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | -2876.446% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -55947.23% |
| Bioventus Inc. | 810.91 Million USD | -115.315% |
| Venus Concept Inc. | 93.65 Million USD | -1764.323% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -6687.223% |
| LivaNova PLC | 2.42 Billion USD | 28.135% |
| 908 Devices Inc. | 202.98 Million USD | -760.185% |
| Alphatec Holdings, Inc. | 805.2 Million USD | -116.84% |
| Nemaura Medical Inc. | 14.56 Million USD | -11889.185% |
| NeuroPace, Inc. | 107.65 Million USD | -1521.92% |
| LENSAR, Inc. | 69.58 Million USD | -2409.18% |
| Apyx Medical Corporation | 79.24 Million USD | -2103.449% |
| Cutera, Inc. | 346.29 Million USD | -404.204% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | -4055.591% |
| BioSig Technologies, Inc. | 1.79 Million USD | -97008.621% |
| Anika Therapeutics, Inc. | 270.63 Million USD | -545.161% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | -3992.762% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 53.833% |
| Axonics, Inc. | 719.92 Million USD | -142.528% |
| Outset Medical, Inc. | 313.8 Million USD | -456.408% |
| IRIDEX Corporation | 34.43 Million USD | -4970.313% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | -331.416% |
| IRadimed Corporation | 92.15 Million USD | -1794.626% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -33132.071% |
| INVO Bioscience, Inc. | 20.88 Million USD | -8259.014% |
| Telesis Bio, Inc. | 70.41 Million USD | -2379.745% |
| Viemed Healthcare, Inc. | 154.1 Million USD | -1033.02% |
| Varex Imaging Corporation | 1.24 Billion USD | -39.726% |
| Quipt Home Medical Corp. | 247.4 Million USD | -605.722% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -18654.168% |
| Pulmonx Corporation | 178.95 Million USD | -875.693% |
| Dynatronics Corporation | 25.94 Million USD | -6630.823% |
| Modular Medical, Inc. | 13.8 Million USD | -12545.854% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -16176.806% |
| Semler Scientific, Inc. | 78.06 Million USD | -2136.614% |
| InMode Ltd. | 863.28 Million USD | -102.252% |
| Bruker Corporation | 4.24 Billion USD | 58.916% |
| Cytosorbents Corporation | 53.26 Million USD | -3178.243% |
| DexCom, Inc. | 6.26 Billion USD | 72.128% |
| Align Technology, Inc. | 6.08 Billion USD | 71.301% |
| Viveve Medical, Inc. | 25.91 Million USD | -6637.981% |
| ZimVie Inc. | 1.2 Billion USD | -44.856% |
| Movano Inc. | 9.42 Million USD | -18433.202% |
| Cytek Biosciences, Inc. | 497.66 Million USD | -250.838% |
| Nexalin Technology, Inc. | 3.63 Million USD | -47974.157% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | -2876.446% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | -83.278% |
| Profound Medical Corp. | 43.68 Million USD | -3896.703% |
| Insulet Corporation | 2.58 Billion USD | 32.539% |
| enVVeno Medical Corporation | 48.63 Million USD | -3490.034% |
| Surmodics, Inc. | 185.73 Million USD | -840.066% |
| iCAD, Inc. | 41.41 Million USD | -4115.59% |
| Nuwellis, Inc. | 9.77 Million USD | -17771.167% |
| Biotricity, Inc. | 5.94 Million USD | -29281.174% |
| iRhythm Technologies, Inc. | 433.14 Million USD | -303.102% |
| Aethlon Medical, Inc. | 8.24 Million USD | -21074.106% |
| InspireMD, Inc. | 47.64 Million USD | -3564.784% |
| PAVmed Inc. | 33.11 Million USD | -5171.938% |
| BIOLASE, Inc. | 35.1 Million USD | -4874.254% |
| Beyond Air, Inc. | 56.96 Million USD | -2965.278% |
| FONAR Corporation | 214.24 Million USD | -714.957% |
| AxoGen, Inc. | 196.82 Million USD | -787.08% |
| Vivani Medical, Inc. | 45.79 Million USD | -3712.505% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | -520.39% |
| Inari Medical, Inc. | 674.23 Million USD | -158.962% |
| UFP Technologies, Inc. | 404.13 Million USD | -332.036% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -7362.053% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -18273.064% |
| Tenon Medical, Inc. | 6.34 Million USD | -27417.935% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -18460.785% |
| Co-Diagnostics, Inc. | 103.64 Million USD | -1584.565% |
| AdaptHealth Corp. | 4.61 Billion USD | 62.206% |
| Sintx Technologies, Inc. | 15.36 Million USD | -11263.573% |
| NanoVibronix, Inc. | 6.67 Million USD | -26061.417% |
| Quanterix Corporation | 425.01 Million USD | -310.816% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -18654.168% |
| Sensus Healthcare, Inc. | 53.72 Million USD | -3149.787% |
| TransMedics Group, Inc. | 706.04 Million USD | -147.294% |
| ReWalk Robotics Ltd. | 63.19 Million USD | -2663.029% |
| NeuroMetrix, Inc. | 21.42 Million USD | -8049.632% |
| Hyperfine, Inc. | 94.19 Million USD | -1753.537% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | -549.943% |
| Biomerica, Inc. | 9.25 Million USD | -18767.657% |
| Bone Biologics Corporation | 3.73 Million USD | -46612.78% |
| AVITA Medical, Inc. | 144.33 Million USD | -1109.653% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -35763.241% |
| Silk Road Medical, Inc | 265.3 Million USD | -558.105% |